The effect of growth hormone on motor findings and dendrite morphology in an experimental Parkinson's disease model

dc.contributor.authorKirazli, Ozlem
dc.contributor.authorOzkan, Mazhar
dc.contributor.authorVerimli, Ural
dc.contributor.authorGulhan, Rezzan
dc.contributor.authorArman, Ahmet
dc.contributor.authorSehirli, Umit Suleyman
dc.date.accessioned2024-10-29T17:58:22Z
dc.date.available2024-10-29T17:58:22Z
dc.date.issued2024
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstractApproaches for the induction of neurogenesis and neuronal recovery through several modalities are gaining popularity in Parkinson's disease (PD). Growth hormone (GH) seems to have a role in the reversal of neural function following brain injury as well as in normal brain development and function; therefore, the use of GH may represent a feasible strategy in the management of PD. This experimental study aimed to evaluate the effect of growth hormone on motor function and dendrite morphology in rats with 6-hydroxydopamine (6-OHDA)-induced PD model. Thirty-six Sprague Dawley rats were included and randomly allocated into one of the six study groups: two controls and four treatment groups that received daily subcutaneous growth hormone injections for 21 days, 1, 2, and 3 months. PD model was induced through unilateral 6-OHDA injection to the nigrostriatal pathway. The following assessments were made: apomorphine rotation test, stepping test, and tissue examinations for tyrosine hydroxylase and dendrite morphology. The apomorphine rotation test and the stepping test confirmed the presence of PD. These tests as well as dendritic spine density/number and length assessments showed improvement in PD findings over time with GH administration. Findings of this study suggest that GH administration may improve dendrite morphology and motor function in the PD model, which may translate into symptom relief and quality of life improvement in patients with PD. Such potential benefits should be tested in robust clinical studies.
dc.description.sponsorshipMarmara niversitesi
dc.description.sponsorshipNo Statement Available
dc.identifier.doi10.1007/s12565-024-00790-6
dc.identifier.issn1447-6959
dc.identifier.issn1447-073X
dc.identifier.pmid39085683
dc.identifier.scopus2-s2.0-85200136509
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1007/s12565-024-00790-6
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14260
dc.identifier.wosWOS:001281328900001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofAnatomical Science International
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectDendrite morphology
dc.subjectExperimental study
dc.subjectGrowth hormone (GH)
dc.subjectMedium spiny neuron
dc.subjectParkinson's disease (PD)
dc.subjectNeural injury
dc.titleThe effect of growth hormone on motor findings and dendrite morphology in an experimental Parkinson's disease model
dc.typeArticle

Dosyalar